Tuberculosis bacteria make a novel stress metabolite to survive immune attack

Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis, survives harsh conditions inside human hosts in part by reprogramming its metabolism. These metabolic adaptations are thought to help the pathogen persist during immune attacks, but until now researchers have largely focused on familiar routes of central carbon metabolism and may have missed other important responses. Corresponding author Robert S. Jansen and colleagues took a different approach: instead of looking only for expected changes, they used an untargeted bottom-up strategy to hunt for unknown stress-responsive metabolites and the enzymes that make them. By exposing Mtb to three stress conditions commonly imposed by the immune system—hypoxia, nitric oxide and activated macrophages—the team tracked small molecules that rose in abundance. They discovered that in all of these stresses the bacterium quickly accumulates very high levels of a previously unidentified compound. Using chemical identification tools they determined this compound is 6’-γ-amino-butyric acid-trehalose, which they call GABA-trehalose. The work reveals that Mtb’s metabolic response to immune stress includes surprising chemistry beyond standard pathways, and sets the stage for understanding why the bacterium produces this new molecule.

The investigators combined untargeted metabolite discovery with biochemical analysis to define how GABA-trehalose is made and when it accumulates. They observed that exposure to hypoxia, nitric oxide and activated macrophages triggers a rapid rise in GABA levels in Mtb; GABA is also released from the cells. At the same time the bacterium produces millimolar quantities of 6’-γ-amino-butyric acid-trehalose (GABA-trehalose). Biochemical experiments showed that GABA-trehalose forms from GABA and trehalose through the action of an uncharacterized ATP-grasp enzyme named Rv1722. The ligation that links the two pieces involves a carboxylate-hydroxyl bond, a non-canonical reaction for ATP-grasp enzymes. Phylogenetic analyses reported by the team demonstrate that the gene rv1722 is found in most slow-growing mycobacteria but is absent from most rapid-growing mycobacteria. The authors also note a likely metabolic driver: increased NADH/NAD+ ratios under hypoxia and nitric oxide exposure would favor GABA formation and inhibit its breakdown, promoting GABA accumulation and excretion unless it is coupled to trehalose by Rv1722.

Taken together, these findings reveal a previously unknown stress-response pathway in Mtb that can rapidly divert large amounts of GABA into the novel metabolite GABA-trehalose. The immediate biological role of GABA-trehalose remains unclear—the authors explicitly state that its function in Mtb metabolism is not yet determined—but the study proposes a plausible metabolic rationale: when NADH/NAD+ ratios rise during immune-imposed stresses, GABA accumulates and either is excreted or is conserved by coupling to trehalose through Rv1722. This coupling provides an alternative to outright loss of carbon and nitrogen, suggesting a resource-conserving strategy under stress. The phylogenetic distribution of rv1722 among slow-growing mycobacteria hints that this pathway may be particularly relevant to pathogens like Mtb. By expanding the map of metabolic responses available to the bacterium, the work by Robert S. Jansen and colleagues opens new directions for research into how Mtb survives the hostile environments it encounters in the host.